MEDP - Medpace Holdings, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Cincinnati,
United States
Type: Equity
MEDP price evolution
MEDP
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $245.45 | $95.21 | $39.14 | $46.92 |
| Short term investments | ||||
| Net receivables | $298.4 | $292.77 | $275.06 | $257.75 |
| Inventory | ||||
| Total current assets | $593.83 | $448.88 | $378.93 | $367.62 |
| Long term investments | ||||
| Property, plant & equipment | $265.39 | $258.91 | $254.68 | $257.06 |
| Goodwill & intangible assets | $698.21 | $698.75 | $699.3 | $699.85 |
| Total noncurrent assets | $1063 | $1037.84 | $1028.01 | $1028.1 |
| Total investments | ||||
| Total assets | $1656.83 | $1486.72 | $1406.94 | $1395.72 |
| Current liabilities | ||||
| Accounts payable | $31.87 | $29.02 | $33.61 | $37.11 |
| Deferred revenue | $559.86 | $518.75 | $490.56 | $466.04 |
| Short long term debt | $55 | $115 | ||
| Total current liabilities | $925.13 | $848.52 | $852.44 | $881.89 |
| Long term debt | $142.12 | $143.04 | $139.39 | $142.69 |
| Total noncurrent liabilities | $172.75 | $167.29 | $163.44 | $166.57 |
| Total debt | $142.12 | $143.04 | $194.39 | $257.69 |
| Total liabilities | $1097.88 | $1015.81 | $1015.88 | $1048.46 |
| Shareholders' equity | ||||
| Retained earnings | -$221.65 | -$300.2 | -$371.02 | -$408.1 |
| Other shareholder equity | -$10.07 | -$12.87 | -$11.19 | -$11.31 |
| Total shareholder equity | $558.95 | $470.91 | $391.06 | $347.26 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $245.45 | $28.27 | $461.3 | $277.77 |
| Short term investments | ||||
| Net receivables | $298.4 | $253.4 | $186.43 | $160.96 |
| Inventory | ||||
| Total current assets | $593.83 | $333.96 | $690.91 | $473.65 |
| Long term investments | ||||
| Property, plant & equipment | $265.39 | $248.92 | $222.71 | $198.83 |
| Goodwill & intangible assets | $698.21 | $700.4 | $703.76 | $708.87 |
| Total noncurrent assets | $1063 | $1018.53 | $969.02 | $917.03 |
| Total investments | ||||
| Total assets | $1656.83 | $1352.49 | $1659.93 | $1390.68 |
| Current liabilities | ||||
| Accounts payable | $31.87 | $33.07 | $25.68 | $26.55 |
| Deferred revenue | $559.86 | $462.73 | $344.64 | $255.66 |
| Short long term debt | $50 | |||
| Total current liabilities | $925.13 | $803.47 | $557.22 | $440.11 |
| Long term debt | $142.12 | $138.87 | $130.97 | $115.14 |
| Total noncurrent liabilities | $172.75 | $162.64 | $149.79 | $144.79 |
| Total debt | $142.12 | $188.87 | $130.97 | $115.14 |
| Total liabilities | $1097.88 | $966.11 | $707.01 | $584.9 |
| Shareholders' equity | ||||
| Retained earnings | -$221.65 | -$359.83 | $234.98 | $115.23 |
| Other shareholder equity | -$10.07 | -$12.39 | -$4.85 | -$0.13 |
| Total shareholder equity | $558.95 | $386.39 | $952.93 | $805.78 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $498.4 | $492.5 | $460.87 | $434.07 |
| Cost of revenue | $361.6 | $359.31 | $336.55 | $303.88 |
| Gross Profit | $136.81 | $133.19 | $124.32 | $130.19 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $42.51 | $41.41 | $39.4 | $38.03 |
| Total operating expenses | $49.49 | $48.28 | $45.92 | $43.98 |
| Operating income | $87.32 | $84.91 | $78.39 | $86.2 |
| Income from continuing operations | ||||
| EBIT | $88.86 | $83.31 | $77.11 | $86.89 |
| Income tax expense | $12.41 | $12.65 | $14.68 | $13.14 |
| Interest expense | -$1.84 | $0.1 | $1.37 | $0.86 |
| Net income | ||||
| Net income | $78.3 | $70.55 | $61.07 | $72.89 |
| Income (for common shares) | $78.3 | $70.55 | $61.07 | $72.89 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1885.84 | $1460 | $1142.38 | $925.92 |
| Cost of revenue | $1361.34 | $1027.56 | $814.22 | $647.2 |
| Gross Profit | $524.5 | $432.44 | $328.15 | $278.73 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $161.35 | $131.4 | $108.42 | $92.16 |
| Total operating expenses | $187.68 | $153.74 | $129.54 | $111.68 |
| Operating income | $336.82 | $278.7 | $198.62 | $167.04 |
| Income from continuing operations | ||||
| EBIT | $336.17 | $285.76 | $201.96 | $168.22 |
| Income tax expense | $52.87 | $37.49 | $20 | $23.15 |
| Interest expense | $0.49 | $2.9 | $0.1 | -$0.31 |
| Net income | ||||
| Net income | $282.81 | $245.37 | $181.85 | $145.38 |
| Income (for common shares) | $282.81 | $245.37 | $181.85 | $145.38 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $78.3 | $70.55 | $61.07 | $72.89 |
| Operating activities | ||||
| Depreciation | $12.04 | $11.8 | $11.42 | $10.71 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.17 | $5.01 | $4.91 | $5.44 |
| Total cash flows from operations | $156.4 | $114.39 | $82.52 | $80.08 |
| Investing activities | ||||
| Capital expenditures | -$9.99 | -$8.7 | -$8.45 | -$9.51 |
| Investments | ||||
| Total cash flows from investing | -$8 | -$8.66 | -$8.47 | -$9.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.52 | $5.73 | -$22.21 | -$117.68 |
| Net borrowings | -$55 | -$60 | $65 | |
| Total cash flows from financing | $1.52 | -$49.27 | -$82.21 | -$52.68 |
| Effect of exchange rate | $0.32 | -$0.38 | $0.38 | $0.77 |
| Change in cash and equivalents | $150.24 | $56.07 | -$7.78 | $18.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $282.81 | $245.37 | $181.85 | $145.38 |
| Operating activities | ||||
| Depreciation | $45.97 | $40.36 | $37.41 | $33.45 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $20.52 | $21.41 | $14.47 | $13.78 |
| Total cash flows from operations | $433.37 | $388.05 | $263.33 | $258.68 |
| Investing activities | ||||
| Capital expenditures | -$36.65 | -$36.88 | -$28.27 | -$31.34 |
| Investments | ||||
| Total cash flows from investing | -$34.63 | -$38.74 | -$31.36 | -$31.21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$132.64 | -$825.77 | -$44.45 | -$82.28 |
| Net borrowings | -$50 | $50 | ||
| Total cash flows from financing | -$182.64 | -$775.77 | -$44.45 | -$82.28 |
| Effect of exchange rate | $1.08 | -$6.57 | -$3.97 | $0.67 |
| Change in cash and equivalents | $217.18 | -$433.04 | $183.54 | $145.85 |
News
Fundamentals
| Market cap | $11.48B |
|---|---|
| Enterprise value | $11.38B |
| Shares outstanding | 30.68M |
| Revenue | $1.89B |
|---|---|
| EBITDA | $382.14M |
| EBIT | $336.17M |
| Net Income | $282.81M |
| Revenue Q/Q | 26.47% |
| Revenue Y/Y | 29.17% |
| P/E ratio | 40.61 |
|---|---|
| EV/Sales | 6.04 |
| EV/EBITDA | 29.78 |
| EV/EBIT | 33.86 |
| P/S ratio | 6.09 |
| P/B ratio | 20.18 |
| Book/Share | 18.55 |
| Cash/Share | 8.00 |
| EPS | $9.22 |
|---|---|
| ROA | 19.02% |
| ROE | 63.98% |
| Debt/Equity | 1.96 |
|---|---|
| Net debt/EBITDA | 2.23 |
| Current ratio | 0.64 |
| Quick ratio | 0.64 |